SCHEMBL4997425

SCHEMBL4997425

NC(=O)c1cccc(-c2nccc(-c3cc4n(n3)CCNC4=O)n2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC7 O00311 1/20 0.48
FYN P06241 5/20 0.41
RPS6KA3 P51812 1/20 0.40
PRKCI P41743 1/20 0.39
MAPKAPK2 P49137 1/20 0.39
PIM1 P11309 1/20 0.39
PIM2 Q9P1W9 1/20 0.39
PDE4B Q07343 2/20 0.38
CCNT1 O60563 1/20 0.38
CCND1 P24385 1/20 0.38
CCNC P24863 1/20 0.38
CDK8 P49336 1/20 0.38
CDK7 P50613 1/20 0.38
CDK9 P50750 1/20 0.38
CCNH P51946 1/20 0.38
MNAT1 P51948 1/20 0.38
CDK6 Q00534 1/20 0.38
PIK3CD O00329 1/20 0.38
PIK3R1 P27986 1/20 0.38
USP30 Q70CQ3 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4997440 0.91 CDC7 (0.49) CDC7MAPKAPK2PIM1PIM2PDE4D
SCHEMBL5002475 0.89 CDC7 (0.47) CDC7MAPKAPK2PIM1PIM2
SCHEMBL4997344 0.88 CDC7 (0.51) CDC7RPS6KA3MAPKAPK2PIM1PIM2
SCHEMBL14188600 0.87 CDC7 (0.46) CDC7MAPKAPK2PIM1PIM2
SCHEMBL4991274 0.86 CDC7 (0.51) CDC7FYNMAPKAPK2PIM1PIM2
SCHEMBL4994437 0.86 CDC7 (0.51) CDC7FYNMAPKAPK2PIM1PIM2
SCHEMBL4991294 0.85 CDC7 (0.52) CDC7MAPKAPK2PIM1PIM2PDE4B
SCHEMBL4990601 0.84 CDC7 (0.56) CDC7PIM1PIM2PDE4B
SCHEMBL5000066 0.84 CDC7 (0.51) CDC7RPS6KA3MAPKAPK2PIM1PIM2
SCHEMBL4994530 0.84 CDC7 (0.51) CDC7RPS6KA3MAPKAPK2PIM1PIM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080113971-A1 PYRAZOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS HANAU CATHLEEN E 2008-05-15 US disclosed
US-20080113971-A1 PYRAZOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS HANAU CATHLEEN E 2008-05-15 US disclosed
US-20080113971-A1 PYRAZOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS HANAU CATHLEEN E 2008-05-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080113971-A1 PYRAZOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS MKNK2, MAPKAPK2, MAP3K2 CDC7 487/4885FYN 331/4885RPS6KA3 76/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.